Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Date:9/9/2009

SEATTLE, Sept. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at BioCentury's NewsMakers in the Biotech Industry conference on Wednesday, September 16, 2009, at 10:30 AM Eastern.

The conference will be held September 16, 2009, at the Millennium Broadway Hotel in New York. The conference will be webcast live with slides and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.

              BioCentury's NewsMakers in Biotech Industry Conference
                 CTI Presentation: Wednesday, September 16, 2009
          10:30 a.m. Eastern /7:30 a.m. Pacific /6:30 p.m. Central European
              Audio webcast with slides at www.celltherapeutics.com

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: media@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
2. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw Healthcare Conference
3. Oxygen Biotherapeutics, Inc. to Present at Investment Conferences in New York and Zurich
4. Cell Therapeutics, Inc. Announces Closing of Registered Offering of $30 Million of Preferred Stock and Warrants
5. Cell Therapeutics, Inc. Announces Institutional Investor Purchases $30 Million of Preferred Stock and Warrants
6. Oxygen Biotherapeutics, Inc. Files 10-K for Fiscal Year Ended April 30, 2009
7. Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure
8. Cell Therapeutics, Inc. Announces Exercise of Overallotment
9. Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
10. Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
11. Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... AMSTERDAM , April 20, 2017 Dutch philosopher Koert ... of ,Next Nature, at the University of Technology in Eindhoven - has ... In this letter, he calls on humanity to avoid becoming a slave and ... race. ... Dutch philosopher Koert van Mensvoort – founder of ...
(Date:4/19/2017)... (PRWEB) , ... April 18, 2017 , ... A number ... advances. This webinar, which is part of the Protein and Cell Analysis Education ... and outline where this technology fits in current and future applications. , Many ...
(Date:4/19/2017)... ... 2017 , ... ThermaGenix, the PCR Improvement Company, announces the ... other early achievements at ThermaGenix, including the business formation and licensing agreements, and ... use proceeds from the Series A-1 round to:, , ...
(Date:4/19/2017)... April 19, 2017  As a Bronze ... Heroin Summit ,  Proove® Biosciences, Inc. announces ... environmental, and lifestyle factors to accurately predict prescription ... of Southern California (USC), the Interventional Pain Institute ... publish results showing that Proove Opioid Risk® accurately ...
Breaking Biology Technology:
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):